Certara: Terrance Ocheltree, VP of regulatory strategy and CMC
Drug development and regulatory science specialists Cetrara has appointed Terrance Ocheltree as vice president of regulatory strategy and chemistry, manufacturing and controls.
In his new role, Ocheltree will provides technical and strategic advice on CMC activities to support product development, from pre-investigational new drug (IND) submission to commercialization and the establishment of supply chains. His past experience includes five years at AbbVie as senior director in regulatory, and eight years at the US Food and Drug Administration (FDA) in the office of new drug quality assessment as a reviewer and division director.